Tuesday, July 14, 2015

10 Best Building Product Stocks To Watch Right Now

10 Best Building Product Stocks To Watch Right Now: Kite Pharma Inc (KITE)

Kite Pharma, Inc., incorporated on June 1, 2009, is a clinical-stage biopharmaceutical company focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company does this using its engineered autologous cell therapy (eACT). eACT involves the genetic engineering of T cells to express either chimeric antigen receptors (CARs, or T cell receptors, or TCRs). These modified T cells are designed to recognize and destroy cancer cells. The Company funds multiple Phase I-2a clinical trials with CAR- and TCR-based therapies that are being conducted by its collaborator, the Surgery Branch of the National Cancer Institute (NCI). The Company plans to conduct a Phase I-2 clinical trial for its lead product candidate KTE-C19, a CAR-based therapy, in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL).

eACT involves harvesting T cells from the patient's blood; genetically engineering T cells to express cancer-specific receptors; increasing the number of engineered T cells and infusing the functional cancer-specific T cells back into the patient. Using eACT technology, T cells can be genetically modified to express one of two classes of cancer-specific receptors: CARs or TCRs. CARs can recognize native cancer antigens that are part of an intact protein presented on the cancer cell surface. TCRs broaden the therapeutic approach by recognizing fragments on the cancer cell surface derived from intracellular proteins. By combining both CAR and TCR approaches, it has the potential to generate a portfolio of products that can target both solid and hematological tumors. It has a Cooperative Research and Development Agreement (CRADA), through which it is funding the research and development o! f eACT-based product candidates utilizing CARs and TCRs for the treatment of advanced solid and hematological malignancies.

The Company's lead product candidate, KTE-C19, ! is an anti-CD19 CAR T cell therapy. CD19 is a protein expressed on the cell surface of B cell lymphomas and leukemias. The Company is an ongoing NCI Phase I-2a clinical trial utilizing anti-CD19 CAR T cell therapy that is designed to establish a dose level and appropriate conditioning regimen, as well as to assess overall safety, in patients with B cell lymphomas and leukemias that had been heavily pretreated and were relapsed/refractory (unresponsive) to chemotherapy. KTE-C19 will use the identical anti-CD19 CAR construct and viral vector that is being used in the NCI trial. The Company a license with the NIH for intellectual property relating to a TCR-based T cell therapy targeting the antigen SSX2 for the treatment of head and neck cancer, hepatocellular carcinoma, melanoma, prostate cancer and sarcoma, and a co-exclusive license to this intellectual property for the treatment of certain additional cancer types.

Advisors' Opinion:
  • [By John Udovich]

    Small cap cancer drug stock Kite Pharma Inc (NASDAQ: KITE) has surged after announcing a strategic research collaboration and license agreement with Amgen, Inc (NASDAQ: AMGN) involving Chimeric Antigen Receptors (CAR) – meaning its worth taking a closer look at the stock, which had an IPO last June, along with potential peers Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) and Juno Therapeutics (NASDAQ: JUNO) which are players in the CAR therapies space and had more recent IPOs.

  • [By Matt Egan]

    While the health-care sector only raised $1.8 billion during the second quarter, it led the way with 24 IPOs, up from 17 the year before. Hot drug IPOs include Zs Pharma (ZSPH), Kite Pharma (KITE) and GlobeImmune (GBIM), all of which debuted in June and are trading more than 40% above their IPO price.

  • [By! John Udo! vich]

    Biotech news this week was dominated by a number of healthcare and biotech related IPOs, including Parnell Pharmaceuticals Holdings Ltd (NASDAQ: PARN), Signal Genetics Inc (NASDAQ: SGNL), ZS Pharma Inc (NASDAQ: ZSPH), Ardelyx Inc (NASDAQ: ARDX) and Zafgen Inc (NASDAQ: ZFGN) with Kite Pharma Inc (NASDAQ: KITE), Microlin Bio Inc (NASDAQ: MCLB) and Syndax Pharmaceuticals Inc (NASDAQ: SNDX) presumably set to debut today (Note: See This Week's Biotech IPOs: Two Losers and One Winner So Far (PARN, SGNL & ZSPH)):

  • source from Top Stocks For 2015:http://www.topstocksblog.com/10-best-building-product-stocks-to-watch-right-now-4.html

Sunday, July 12, 2015

10 Best Dividend Stocks To Watch Right Now

10 Best Dividend Stocks To Watch Right Now: Integrys Energy Group(TEG)

Integrys Energy Group, Inc., through its subsidiaries, operates as a regulated electric and natural gas utility company in the United States and Canada. It provides natural gas utility services in Chicago, Wisconsin, Michigan, and Minnesota. As of December 31, 2009, the company served approximately 1,669,000 residential, commercial and industrial, transportation, and other customers. It had approximately 22,000 miles of natural gas distribution mains; and approximately 1,010 miles of natural gas transmission mains. The company also generates and distributes electric energy form coal, natural gas, fuel oil, hydroelectric, and wind resources in Wisconsin and Michigan. It served approximately 489,000 residential, commercial and industrial, wholesale, and other customers. In addition, Integrys Energy offers nonregulated energy supply and services; and electric transmission services. The company was formerly known as WPS Resources Corporation and changed its name to Integrys En ergy Group, Inc. in February 2007. Integrys Energy Group, Inc. was founded in 1883 and is based in Chicago, Illinois.

Advisors' Opinion:
  • [By Johanna Bennett]

    Among the sector's best performers are Integrys Energy (TEG), Edison International (EIX), Entergy (ETR), and Pepco Holdings (POM).

    Investors' attraction to utility stocks stems in part to their above-market payouts. The Utilities Select Sector SPDR ETF (XLU) has climbed roughly 25% this year, not including its 3.24% dividend.

  • [By Jayson Derrick]

    Exelon (NYSE: EXC) has agreed to acquire the retail electricity division of Integrys Energy (NYSE: TEG) for $60 million. Shares of Exelon lost 1.46 percent, closing at $31.01 while shares of Integrys Energy lost 2.16 percent, closing at $67.54.

  • [By David Dittman]

    Parti! cipation was still robust, thanks to a highly engaged group of readers.

    Utility stocks set the pace for the broader market over the first six months of 2014, as fears of rising interest rates abated and companies produced solid first-quarter financial and operating numbers.

    Second-quarter reporting season will get underway later in July, with most management teams posting results in early August.

    There's also been significant mergers-and-acquisitions rumor and activity, notably surrounding the telecom space. And Wisconsin Energy Corp (NYSE: WEC) last week announced a deal to buy UF Portfolio Holding Integrys Energy Group Inc (NYSE: TEG) for $9.1 billion in cash, stock and assumed debt.

    Canadian stocks are back to their winning ways thus far in 2014, with the S&P/TSX Composite Index posting a 12.5 percent total return in US dollar terms from Dec. 31, 2013, through June 30, 2014. The S&P 500 Index is up 7.1 percent, the MSCI Wor ld Index 6.6 percent.

    The loonie, meanwhile, was strong in June, bouncing back to near USD0.94 and having an essentially neutral impact for US-based investors' returns for the first six months of the year.

    The Australia dollar pushed out to an eight-month high earlier this week, as Chinese PMI data showed some stabilization in the economy for that key trading partner. Although iron ore prices remain depressed, several LNG projects coming on line in coming months should give a boost to Australian exports.

    Aussie strength has had a clear positive impact for US-based investors who are long Australian stocks. The S&P/ASX 200 Index trailed the S&P 500 and the MSCI World Index with a 3 percent return in local terms. Accounting for the impact of a stronger aussie on US investors' holdings, the S&P/ASX was up 8.8 percent from Dec. 31, 2013, through June 30, 2014.

    Here are highlights in the form of a slightly edited transcript from the July 2 "June" AE/

  • source from Top Stocks For 2015:http://www.topstocksblog.com/10-best-dividend-stocks-to-watch-right-now-4.html

Thursday, July 9, 2015

10 Best Income Stocks For 2016

10 Best Income Stocks For 2016: Chimerix Inc (CMRX)

Chimerix, Inc., incorporated on April, 07, 2000, is a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need. Its lipid technology has given rise to two clinical-stage compounds, CMX001 and CMX157, which have demonstrated the potential for enhanced antiviral activity and safety in convenient, orally administered dosing regimens.

CMX001 is an orally administered drug that utilizes its lipid technology to deliver intracellular concentrations of a potent antiviral compound, cidofovir-diphosphate (CDV-PP). Following oral dosing, CMX001 is absorbed through the gut, remains intact in the plasma, and is readily taken up by and delivered into cells. Once inside cells, CMX001 is converted into CDV-PP, which acts as an alternative substrate in a replicating virus. CMX001 is similar to the drug cidofovir in that both drug s are converted into CDV-PP once inside cells. Although cidofovir is approved for administration in an intravenous formulation, Vistide, it requires a plasma concentration to deliver a therapeutic level of cidofovir into cells and its use is limited due to the risk of kidney damage.

CMX157, Its second clinical stage compound, is an oral nucleotide compound in Phase 1 development for the treatment of human immunodeficiency virus (HIV) infection. In July 2012, the Company granted Merck an exclusive worldwide license to develop and commercialize CMX157 for all human uses. Merck is responsible for all development and marketing activities for CMX157 on a worldwide basis.

Advisors' Opinion:
  • [By Ben Levisohn]

    Biotech companies that are most likely to benefit because they are “Ahead in clinical development and/or have established relationships with [th! e Biomedical Advanced Research and Development Authority, or] BARDA which may facilitate getting a contract” include GlaxoSmithKline (GSK), NewLink Genetics (NLNK), Johnson & Johnson (JNJ) and Chimerix (CMRX). Kantor includes Tekmira (TKMR) and Sarepta (SRPT) among “companies with viable programs” that are “moving forward and likely to attract additional funding.”

  • source from Top Stocks For 2015:http://www.topstocksblog.com/10-best-income-stocks-for-2016-2.html

Monday, July 6, 2015

Hot Restaurant Companies To Invest In 2016

Hot Restaurant Companies To Invest In 2016: Planet Platinum Ltd (PPN)

Planet Platinum Limited is an Australia-based company engaged in the operation of Showgirls Bar 20 and the on-going rental of property in Elsternwick. The Company operates in two segments: hospitality and entertainment and property rental businesses. The Company's hospitality and entertainment segment comprises operations of Showgirls Bar 20 in Melbourne and is engaged in the nightclub through the provision of beverages and adult entertainment. Property segment comprise maintaining of rental property at Home Street, Elsternwick. The Company continues to receive lease rentals from its Home Street property. The investment property is located at 12 Home Street, Elsternwick Victoria. Advisors' Opinion:
  • [By Tabitha Jean Naylor]

    Americans consume a lot of chicken. It estimated that Americans consume about 81 pounds of poultry per year, per capita. With there being upwards of 310 million people living in the United States, it is no wonder why poultry production is big business. Two of the biggest names in poultry production are Tyson Foods (NYSE: TSN) and Pilgrim's Pride (NASDAQ: PPN).

  • source from Top Stocks For 2015:http://www.topstocksblog.com/hot-restaurant-companies-to-invest-in-2016.html

Wednesday, July 1, 2015

Top Specialty Retail Companies To Invest In 2016

Top Specialty Retail Companies To Invest In 2016: CSS Industries Inc (CSS)

CSS Industries, Inc. (CSS), incorporated on November 5, 1923, is a company primarily engaged in the design, manufacture, procurement, distribution and sale of seasonal and all occasion social expression products, principally to mass market retailers. These seasonal and all occasion products include gift wrap, gift bags, gift boxes, gift card holders, boxed greeting cards, gift tags, decorative tissue paper, decorations, classroom exchange Valentines, decorative ribbons and bows, floral accessories, Halloween masks, costumes, make-up and novelties, Easter egg dyes and novelties, craft and educational products, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, and other gift items that commemorate life's celebrations. In September 5, 2012, it sold the Halloween portion of its Paper Magic business to Gemmy Industries (HK) Limited.

CSS' product provides its retail customers the opportunity to use a single ven dor for much of their seasonal product requirements. A substantial portion of CSS' products are manufactured, packaged and/or warehoused in 10 facilities located in the United States, with the remainder purchased primarily from manufacturers in Asia and Mexico. The Company's products are sold to its customers by national and regional account sales managers, sales representatives, product specialists and by a network of independent manufacturers' representatives. The Company's principal operating subsidiaries include Paper Magic Group, Inc. (Paper Magic), Berwick Offray LLC (Berwick Offray) and C.R. Gibson, LLC (C.R. Gibson). CSS designs, manufactures, procures, distributes and sells a range of seasonal consumer products primarily through the mass market distribution channel. Christmas products include gift wrap, gift bags, gift boxes, gift card ! holders, boxed greeting cards, gift tags, decorative tissue paper and decorations. CSS' Valentine product offerings includ e classroom exchange Valentine cards and other related Valen! tine products, while its Easter product offerings include Dudley's brand of Easter egg dyes and related Easter seasonal products. CSS also designs and markets decorative ribbons and bows, all occasion boxed greeting cards, gift wrap, gift bags, gift boxes, gift card holders, decorative and waxed tissue, decorative films and foils, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, floral accessories and other gift and craft items to its mass market, craft, specialty and floral retail and wholesale distribution customers, and teachers' aids and other learning oriented products to the education market through mass market retailers, school supply distributors and teachers' stores. Key brands include Paper Magic, Berwick, Offray, C.R. Gibson, Markings, Creative Papers, Tapestry, Dudley's, Don Post Studios, Eureka, Learning Playground, Stickerfitti and iota. Key brands include Paper Magic, Berwick, Offray, C.R. Gibson, Markin gs, Creative Papers, Tapestry, Seastone, Dudley's, Eureka, Learning Playground and Stickerfitti.

CSS operates 10 manufacturing and/or distribution facilities located in Pennsylvania, Maryland, New Hampshire, South Carolina, Alabama and Texas. Its boxed greeting cards are produced by Asian manufacturers to the Company's specifications. Halloween make-up and Easter egg dye products are manufactured in Asia to specific formulae by contract manufacturers who meet regulatory requirements for the formularization and packaging of such products. Ribbons and bows are primarily manufactured and warehoused in seven facilities located in Pennsylvania, Maryland, South Carolina and Texas. Memory books, stationery, journals and notecards, infant and wedding photo albums, scrapbooks, and other gift items are imported from Asian manufacturers and! warehous! ed and distributed from a distribution facility in Florence, Alabama. Floral accessories, including pot covers, foil, waxe d tissue, shred, aisle runners, corsage bags and other paper! and film! products, are manufactured in a facility located in Milford, New Hampshire and Juarez, Mexico. Manufacturing includes gravure and flexo printing, waxing and converting. Products are warehoused and distributed from a distribution facility in Berwick, Pennsylvania. Other products including, but not limited to, decorative tissue paper, all occasion gift wrap, gift tags, gift bags, gift boxes, gift card holders, classroom exchange Valentine products, Halloween masks, costumes and novelties, Easter products, decorations and school products are designed to the specifications of CSS and are imported primarily from Asian manufacturers.

Advisors' Opinion:
  • [By Rich Duprey]

    Gifts maker CSS Industries  (NYSE: CSS  )  announced yesterday its second-quarter dividend of $0.15 per share, the same rate it's paid since 2008.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-specialty-retail-companies-to-invest-in-2016.html